On February 13, 2025, Aarons Holdings Company Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Georgia on behalf of all former beneficial owners of The Aaron’s Company common stock at the time of the closing of the acquisition of The Aaron’s Company (the “Transaction”) by IQVentures Holdings, LLC (“IQV”) whereby The Aaron’s Company’s stockholders received $10.10 in cash for each share of The Aaron’s Company common stock that they held before the Transaction ("Merger Consideration").

On February 12, 2025, Merck & Co., Inc. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Merck securities between February 3, 2022, to February 3, 2025, inclusive (the “Class Period”).

On February 11, 2025, Intellia Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased or otherwise acquired Intellia securities between July 30, 2024 to January 8, 2025, inclusive (the “Class Period”).

On February 11, 2025, Elastic N.V. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased or otherwise acquired Elastic securities between May 31, 2024 and August 29, 2024, both dates inclusive (the “Class Period”).

On February 10, 2025, ICON PLC was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the “Class Period”).

On February 6, 2025, Neumora Therapeutics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of a class of all persons or entities who purchased or otherwise acquired Neumora common stock pursuant and/or traceable to the Offering Documents (as defined herein) issued in connection with the IPO, and who were damaged thereby (the “Class”).

On February 4, 2025, GSK plc was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Pennsylvania on behalf of all purchasers of the American Depositary Receipts (“ADRs”) of GSK between February 5, 2020, and August 14, 2022, inclusive (the “Class Period”).

On February 4, 2025, Monolithic Power Systems was sued for violations of the federal securities laws in the United States District Court for the Western District of Washington on behalf of all purchasers of Monolithic common
stock between February 8, 2024 and November 8, 2024, inclusive (the “Class Period”).

On January 31, 2025, Newmont Corporation was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased or otherwise acquired Newmont securities between February 22, 2024 and October 23, 2024, inclusive (the “Class Period”).

On January 31, 2025, Target Corporation was sued for violations of the federal securities laws in the United States District Court for the Middle District of Florida on behalf of investors who purchased or otherwise acquired Target common stock between August 26, 2022 and November 19, 2024, inclusive (the “Class Period”).

On January 30, 2025, Walgreens Boots Alliance, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Illinois on behalf of investors who purchased or otherwise acquired Walgreens common stock between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”).

On January 30, 2025, Polestar Automotive Holding UK PLC was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired publicly traded securities between November 14, 2022 and January 16, 2025, both dates inclusive (the “Class Period”).

On January 30, 2025, TELUS International (Cda) Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise
acquired Telus International securities between February 16, 2023 and August 1, 2024, inclusive (the “Class Period”).

On January 30, 2025, Grocery Outlet Holding Corp. was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased or
otherwise acquired Grocery Outlet securities between November 7, 2023, to May 7, 2024, inclusive (the “Class Period”).

On January 29, 2025, Arconic Corporation was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who sold publicly
traded shares of Arconic common stock between April 19, 2022 and May 3, 2023, both dates inclusive (the “Class Period”).

On January 29, 2025, Integral Ad Science Holding Corp. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased
shares of IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

On January 29, 2025, ModivCare, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased or otherwise
acquired ModivCare securities between November 3, 2022, and September 15, 2024, inclusive (the “Class Period”).

On January 24, 2025, ESSA Pharma Inc. was sued for violations of the federal securities laws in the  United States District Court for the District of Wisconsin on behalf of investors who purchased or otherwise acquired ESSA securities between December 12, 2023 and October 31, 2024, both dates inclusive (the “Class Period”).

On January 24, 2025, Novo Nordisk A/S was sued for violations of the federal securities laws in the  United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Novo securities between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

On January 22, 2025, Cardlytics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Northern District of Georgia on behalf of investors who purchased the Company’s shares between March 14, 2024 and August 7, 2024, inclusive (the “Class Period”).